- Compare and contrast emerging technologies for the deterrence of opioid abuse
- Assess the effectiveness of abuse-deterrent formulations to control pain and potential impact on abuse
- Assess patient safety profiles, legal and regulatory implications of current and emerging opioid therapy
- Improve overall patient outcomes through better identification of those likely to abuse or divert opioids
There is no fee for this activity as it is sponsored by PRIME
® through an independent educational grant from King Pharmaceuticals, Inc.
No comments:
Post a Comment